Your browser doesn't support javascript.
loading
FAT10 differentially stabilizes MYPT2 isoforms.
Song, Seong Eun; Kim, Yerin; Jeong, Hoim; Lee, Beomgu; Lee, Jihyeon; Roh, Jong Seong; So, Min Wook; Lee, Seung-Geun; Sohn, Dong Hyun.
  • Song SE; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Kim Y; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Jeong H; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Lee B; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Lee J; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Roh JS; Department of Herbal Prescription, College of Korean Medicine, Daegu Haany University, Gyeongsan, Republic of Korea.
  • So MW; Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
  • Lee SG; Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Republic of Korea.
  • Sohn DH; Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea. Electronic address: dhsohn@pusan.ac.kr.
Biochem Biophys Res Commun ; 676: 115-120, 2023 10 08.
Article en En | MEDLINE | ID: mdl-37506472
ABSTRACT
Myosin phosphatase (MP) is an enzyme complex that regulates muscle contraction and plays important roles in various physiological and pathological conditions. Myosin phosphatase targeting subunit (MYPT) 2, a subunit of MP, interacts with protein phosphatase 1c to regulate its phosphatase activity. MYPT2 exists in various isoforms that differ in the composition of essential motifs that contribute to its function. However, regulatory mechanisms underlying these isoforms are poorly understood. Human leukocyte antigen-F adjacent transcript 10 (FAT10) is a ubiquitin-like modifier that not only targets proteins for proteasomal degradation but also stabilizes its interacting proteins. In this study, we investigated the effect of the interaction between FAT10 and MYPT2 isoform a (the canonical full-length form of MYPT2) or MYPT2 isoform f (the natural truncated form of MYPT2). FAT10 interacted with both MYPT2 isoforms a and f; however, only MYPT2 isoform f was increased by FAT10, whereas MYPT2 isoform a remained unaffected by FAT10. We further confirmed that, in contrast to MYPT2 isoform a, MYPT2 isoform f undergoes rapid degradation via the ubiquitin-proteasome pathway and that FAT10 stabilizes MYPT2 isoform f by inhibiting its ubiquitination. Therefore, our findings suggest that the interaction between FAT10 and MYPT2 isoforms leads to distinct stabilization effects on each isoform, potentially modulating MP activity.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ubiquitinas / Ubiquitina Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ubiquitinas / Ubiquitina Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article